AAM Sees Extended Support For BIOSIM Act
Multiple US Organizations Come Together To Back Add-On Payment For Biosimilars
US representatives Kurt Schrader and Adam Kinzinger have introduced the BIOSIM Act to improve access and realize the full potential of biosimilars by encouraging an additional payment for providers when they use a biosimilar cheaper than the reference biologic. AAM and a group of organizations have extended support to the bipartisan bill.
